+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

3-Kinase Delta Syndrome Market - Global Forecast 2025-2030 - Product Thumbnail Image

3-Kinase Delta Syndrome Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
Enzyme Inhibitor Market - Global Forecast 2025-2030 - Product Thumbnail Image

Enzyme Inhibitor Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
From
From
From
From
From
Large Molecule Injectable Drugs Market 2024-2028 - Product Thumbnail Image

Large Molecule Injectable Drugs Market 2024-2028

  • Report
  • July 2024
  • 166 Pages
  • Global
From
Small Molecule Drug Discovery - Global Strategic Business Report - Product Thumbnail Image

Small Molecule Drug Discovery - Global Strategic Business Report

  • Report
  • September 2025
  • 376 Pages
  • Global
From
Cold Pain Therapy Market Report 2025 - Product Thumbnail Image

Cold Pain Therapy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Industry Snapshots: US Biotechnology - Product Thumbnail Image

Industry Snapshots: US Biotechnology

  • Newsletter
  • September 2025
  • 50 Pages
  • United States
From
Pharmaceutical Drugs Industry: Global Competitive Landscape 2021 - Product Thumbnail Image

Pharmaceutical Drugs Industry: Global Competitive Landscape 2021

  • Report
  • October 2022
  • 307 Pages
  • Global
From
From
Loading Indicator